MassBio’s Spring 2026 Accelerator Cohort Apps open
The application for MassBio’s Drive’s Spring 2026 accelerator cohorts is now open until January 16, 2026, at 12:00 PM (noon) ET. For this upcoming cycle, the programs will focus on:
- Biotech, powered by MassBio: Scientific founders or emerging startups with a therapeutic pipeline or platform with an asset.
- Biomarkers & Diagnostics, powered by SCbio: Scientific founders or emerging startups using machine learning, high-performance or quantum computing to identify or develop biomarkers, diagnostics, and tests that stratify patients, predict disease progression, or accelerate therapeutic selection.
A quick refresher about Drive:
- Drive is an accelerator program designed to advance breakthrough science while providing opportunities to innovators from all parts of the life sciences ecosystem. Drive supports academic founders or pre-seed biotechs or techbio startups who are looking to launch and grow their businesses.
- Twice a year (through spring and fall cohorts), MassBio and SCbio partner to accelerate 10 groundbreaking scientists or startups by connecting them with life sciences business curriculum, mentorship, industry connections, and benefits during an 8-week program.
- The program is run hybrid – curriculum and mentoring meetings are virtual, while networking events and Demo Days in Boston and Charleston take place in person. This enables us to connect exceptional founders with a diverse pool of investors.
- Since launching in 2022, Drive alumni have raised $47M and created 95+ jobs.
Learn more: (https://drive.slideroom.com/#/Login)